Evidence-based clinical use of insulin premixturesReportar como inadecuado

Evidence-based clinical use of insulin premixtures - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Diabetology and Metabolic Syndrome

, 5:50

First Online: 06 September 2013Received: 13 November 2012Accepted: 17 May 2013


Brazil is expected to have 19.6 million patients with diabetes by the year 2030. A key concept in the treatment of type 2 diabetes mellitus T2DM is establishing individualized glycemic goals based on each patient’s clinical characteristics, which impact the choice of antihyperglycemic therapy. Targets for glycemic control, including fasting blood glucose, postprandial blood glucose, and glycated hemoglobin A1C, are often not reached solely with antihyperglycemic therapy, and insulin therapy is often required. Basal insulin is considered an initial strategy; however, premixed insulins are convenient and are equally or more effective, especially for patients who require both basal and prandial control but desire a more simplified strategy involving fewer daily injections than a basal-bolus regimen. Most physicians are reluctant to transition patients to insulin treatment due to inappropriate assumptions and insufficient information. We conducted a nonsystematic review in PubMed and identified the most relevant and recently published articles that compared the use of premixed insulin versus basal insulin analogues used alone or in combination with rapid-acting insulin analogues before meals in patients with T2DM. These studies suggest that premixed insulin analogues are equally or more effective in reducing A1C compared to basal insulin analogues alone in spite of the small increase in the risk of nonsevere hypoglycemic events and nonclinically significant weight gain. Premixed insulin analogues can be used in insulin-naïve patients, in patients already on basal insulin therapy, and those using basal-bolus therapy who are noncompliant with blood glucose self-monitoring and titration of multiple insulin doses. We additionally provide practical aspects related to titration for the specific premixed insulin analogue formulations commercially available in Brazil.

KeywordsType 2 diabetes mellitus Insulin Premixed Lispro Glycated hemoglobin Treatment goals Titration  Download fulltext PDF

Autor: Marcos Antônio Tambascia - Márcia Nery - Jorge Luiz Gross - Mariana Narbot Ermetice - Carolina Piras de Oliveira

Fuente: https://link.springer.com/

Documentos relacionados